Last reviewed · How we verify
Atorvastatin or Rosuvastatin
Atorvastatin or Rosuvastatin is a Small molecule drug developed by Wenzhou Medical University. It is currently FDA-approved. Also known as: Liptor, Crestor.
Atorvastatin and Rosuvastatin, marketed by Wenzhou Medical University, are established statins with a significant presence in the lipid-lowering market. A key strength is the extended market exclusivity until 2028, protected by a key composition patent. The primary risk is the intense competition from other statins and generic alternatives.
At a glance
| Generic name | Atorvastatin or Rosuvastatin |
|---|---|
| Also known as | Liptor, Crestor |
| Sponsor | Wenzhou Medical University |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- A Study of Bempedoic Acid/Ezetimibe/High-intensity Statin in Patients Without Cardiovascular Events (PHASE3)
- Moderate-intensity Statin vs. Individualized LDL-C Target-based Therapy in Older Adults With Type 2 Diabetes (iTARGET-Elderly Study) (NA)
- Focusing on the Menopausal Transition to Improve Mid-Life Women's Health (PHASE2, PHASE3)
- A Study of Bempedoic Acid in Combination With Ezetimibe and Either Rosuvastatin or Atorvastatin in Patients With Primary Hypercholesterolemia or Mixed Dyslipidemia
- Efficacy and Safety of Early Combined Therapy With PCSK9 Inhibitors and Statins in Acute Ischemic Stroke (PHASE2, PHASE3)
- Women's IschemiA TRial to Reduce Events In Non-ObstRuctive CAD (PHASE4)
- Statins Effect on Incidence of Side Effects of Platinum Based Chemotherapy (PHASE1, PHASE2)
- Effects of Short-term Intensive Statin Therapy on Lipid Levels
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Atorvastatin or Rosuvastatin CI brief — competitive landscape report
- Atorvastatin or Rosuvastatin updates RSS · CI watch RSS
- Wenzhou Medical University portfolio CI
Frequently asked questions about Atorvastatin or Rosuvastatin
What is Atorvastatin or Rosuvastatin?
Who makes Atorvastatin or Rosuvastatin?
Is Atorvastatin or Rosuvastatin also known as anything else?
What development phase is Atorvastatin or Rosuvastatin in?
Related
- Manufacturer: Wenzhou Medical University — full pipeline
- Also known as: Liptor, Crestor
- Compare: Atorvastatin or Rosuvastatin vs similar drugs
- Pricing: Atorvastatin or Rosuvastatin cost, discount & access